急性脑梗塞患者治疗前后血NSE及GST的检测及其临床意义  

Determination of NSE and GST Levels Before and After Treatment in Patients with Acute Cerebral Infarction and Its Clinical Significance

作　　者：唐小玲[1] 毛绍蓉 

机构地区：[1]内江市第二人民医院核医学科,四川内江641003

出　　处：《标记免疫分析与临床》2010年第3期150-151,共2页Labeled Immunoassays and Clinical Medicine

摘　　要：探索急性脑梗塞患者治疗前后血神经元特异性烯醇化酶(NSE)和谷胱甘肽-S-转移酶(GST)的变化及其意义。64例急性脑梗塞患者作为研究组,44名健康体检者为对照组,用RIA法测定NSE含量,用EIA法测定GST含量,数据用PEMS3.1软件处理。结果表明:研究组NSE和GST含量与对照组比较均有显著性差异(P<0.05),且两指标在治疗前后比较亦有显著性差异(P<0.05)。NSE和GST的监测可以及时了解急性脑梗塞患者病情变化,并可以动态评估治疗效果。To explore the changes of NSE and GST levels before and after treatment in patient with acute cerebral infarction and its clinical significance,the plasma NSE levels and serum GST levels in 64 patients with acute cerebral infarction and in 44 health controls were determined by RIA and EIA respectively.The results showed that there was significantly difference in the levels of NSE and GST between two groups,as well as before and after treatment.The determination of NSE and GST levels might be helpful in the diagnosis of patient with acute cerebral infarction and to assess the therapeutic efficacy dynamically.

关 键 词：急性脑梗塞 测定 神经元特异性烯醇化酶 谷胱甘肽-S-转移酶 放射免疫分析技术 

分 类 号：R743.3[医药卫生—神经病学与精神病学]